Could a ketone drink help stabilize bipolar disorder?
NCT ID NCT06335875
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small pilot study tested whether a ketone ester drink combined with a low-glycemic diet could help people with bipolar disorder. Fifteen adults with bipolar I or II took the supplement twice daily and made simple diet changes for several weeks. Researchers measured blood ketone levels and glucose stability to see if the approach was feasible and had any effect on mood symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ketone ester beverage (Juvenescence Cognitive Switch™) and a low-glycemic-index diet
- What this could lead to
- If it works, this could point toward a dietary approach to help stabilize mood in bipolar disorder.
- What could go wrong
- This is a very small, early pilot study with only 15 people and no placebo group, so results may not be reliable or apply to everyone. The diet and supplement may be hard to stick with long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 and older * Able to provide informed consent * Diagnosis of bipolar disorder, type I or II as determined primarily via medical/psychiatric documentation provided from mental health provider with patient consent * Regular access to smart phone capable of syncing biometric wearable data collection * If taking psychiatric medications, on stable regimen as defined by no medication changes for mood stabilizers and/or antipsychotics in prior 4 weeks Exclusion Criteria: * Inability to adhere to dietary changes as specified in protocol (e.g., not in control of food selection) * History of moderate-to-severe traumatic brain injury, e.g. loss of consciousness \> 10 min, neurologic sequela * Evidence of large vessel stroke or mass lesion on previous MRI or MRI obtained during study * History of significant GI disease (e.g., malabsorptive disorder, gastric cancer, intestinal resection) * Pregnancy (as determined via urine pregnancy test at study initiation), if capable of becoming pregnant, or breastfeeding * Unwilling to utilize birth control method during course of study (e.g., barrier contraception, oral contraceptive, IUD), if capable of becoming pregnant * Currently receiving treatment with insulin (e.g., chronic pancreatitis, diabetes mellitus) * History of mitochondrial disorder and/or significant uncontrolled metabolic/medical disorder * Active/current illicit substance use (and/or consumption of \>1 alcoholic beverages per day) - defined as using psychoactive medications not as prescribed or using illicit substances (as determined via urine drug screen and screening interview) * Use of marijuana or THC products more than once monthly on average * Subjects with contra-indications to MR imaging, including pacemakers or severe claustrophobia, and/or size incompatible with scanner gantry, e. g., men over 6 feet tall that weigh more than 250 lbs, men under 6 feet tall that weigh over 220 lbs, women over 5'11" tall that weigh more than 220 lbs, or women under 5'10" tall that weigh more than 200 lbs. Subjects of these weights or greater typically have difficult fitting into the fMRI scanner properly. * Suicidal thoughts with plans or intentions, as assessed by C-SSRS * Any other condition or criteria that would preclude safe and meaningful participation in this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Domino's Farms
Ann Arbor, Michigan, 48105, United States
-
University Hospital
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five sessions to quiet trauma nightmares in bipolar disorder
- Sound waves vs. depression: can focused ultrasound lift mood?
- Smartphone sensors may predict bipolar mood swings before they strike
- Can a 6,000-Person study unlock personalized depression care for asians?
- Zapping the brain to reset mood and metabolism?
- Can learning Self-Compassion break the chains of mental health stigma?